Neglected tropical diseases (NTDs) remain major public health problems in developing
countries. Reducing the burden of NTDs requires sustained collaborative drug discovery …

Visceral leishmaniasis (VL), a vector-borne disease, is caused by an obligate
intramacrophage, kinetoplastid protozoan parasite of the genus Leishmania. Globally, VL is …

Amphotericin B (AmpB) is a polyene macrolide antibiotic used in the treatment of blood-
borne parasitic and fungal infections. However, its use, particularly in the developing world …

Nanotechnology is revolutionizing many sectors of science, from food preservation to
healthcare to energy applications. Since 1995, when the first nanomedicines started being …

Leishmaniasis is an infectious disease responsible for a huge rate of morbidity and mortality
in humans. Chemotherapy consists of the use of pentavalent antimonial, amphotericin B …

A novel mucomimetic and biocompatible nanocarrier, carboxymethyl tamarind seed
polysaccharide (CMTSP) nanoparticles, were synthesized using ionic gelation. The …

Melatonin (MLT) exhibits antioxidant, ultraviolet protection, anti-inflammatory, and anti-aging
properties. However, its effectiveness is limited by instability, a short half-life, and …

Visceral leishmaniasis (VL) is the most lethal of all leishmaniasis diseasesand the second
most common parasiticdisease after malaria and, still, categorized as a neglected tropical …

Melatonin (MEL), an indoleamine hormone synthesized in almost all organisms including
humans, has been the object of a considerable body of research due to its pleiotropic …

Leishmaniasis, one of the most overlooked tropical diseases, is a life-threatening illness
caused by the parasite Leishmania donovani that is prevalent in underdeveloped nations …